Summary |
|
||||||||
Variant origin |
|
||||||||
Variant description |
|
||||||||
Notes |
Mapping and Phenotype information for this QTL, its variants and associated markersJ:118795Genetic modifiers of ocular dysgenesis were mapped in 100 transgenic animals from a (BALB/cJ x C57BL/6J)F1 x C57BL/6J-Tg(AgrnCFP2R9)1Rwb backcross. Parental strain C57BL/6J appears to be sensitized to spontaneous occurrence of eye defects which is compounded by Agrn overexpression. Genome scan was performed with 140 SNP markers spaced approximately 10 Mb apart. Significant linkage to microphthalmia and anophthalmia susceptibility in the presence of Tg(AgrnCFP2R9)1Rwb mapped to 35 cM on mouse Chromosome 2 (P<0.001). This locus is named Mpaps1 (microphthalmia anophthalmia susceptibility 1). The QTL interval is located between SNP markers rs3692748 and rs3681694 and spans a 16 Mb region. Transgenic backcross animals homozygous for C57BL/6J-derived alleles at Mpaps1 display microphthalmia and anophthamlmia with 35% penetrance. Pax6 at 58 cM is a potential candidate gene for Mpaps1. Mutations in Pax6 have previously been shown to result in eye defects.Nearly suggestive loci mapped to 0 cM on chromosome 13 for persistent hyperplastic primary vitreous (PHPV), 65 cM on chromosome 4 for fetal fissure coloboma, 55 cM on chromosome 2 for lens cornea fusion, and 5 cM on chromosome 12 for iris cornea fusion. |
||||||||
References |
|
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 11/19/2024 MGI 6.24 |
|
|